In a previous study, we demonstrated that the developments CRCs were significantly suppressed following the siRNA mediated AKT knockdown and suggested the AKT as a potential target for the treatment of colorectal cancers with high SLPI expression. Here, AKT1 is linked to colorectal cancer.